Terms: = Lung cancer AND FH, HLRCC, 2271, ENSG00000091483, MCUL1, MCL, LRCC, P07954 AND Treatment
222 results:
1. Humoral complementomics - exploration of noninvasive complement biomarkers as predictors of renal cancer progression.
Revel M; Rezola Artero M; Hamidi H; Grunenwald A; Blasco L; Vano YA; Marie Oudard S; Sanchez-Salas R; Macek P; Rodriguez Sanchez L; Cathelineau X; Vedié B; Sautes-Fridman C; Herman Fridman W; Roumenina LT; Dragon-Durey MA
Oncoimmunology; 2024; 13(1):2328433. PubMed ID: 38487624
[TBL] [Abstract] [Full Text] [Related]
2. Metformin and buparlisib synergistically induce apoptosis of non-small lung cancer (NSCLC) cells via Akt/FoxO3a/Puma axis.
Shanshan W; Hongying M; Jingjing F; Rui Y
Toxicol In Vitro; 2024 May; 97():105801. PubMed ID: 38479708
[TBL] [Abstract] [Full Text] [Related]
3. Anlotinib Inhibits Cisplatin Resistance in Non-Small-Cell lung cancer Cells by Inhibiting mcl-1 Expression via MET/STAT3/Akt Pathway.
Wang L; Xu L; Han S; Zhu X
Can Respir J; 2024; 2024():2632014. PubMed ID: 38468814
[TBL] [Abstract] [Full Text] [Related]
4. Antiproliferative activities of some selected Nigerian medicinal plants against breast, liver, and cervical cancer cells.
Olaleye OO; Kim DH; Spriggs KA
BMC Complement Med Ther; 2024 Mar; 24(1):110. PubMed ID: 38448883
[TBL] [Abstract] [Full Text] [Related]
5. Acute mast cell leukemia without KIT D816V mutation and lack of CD2 and CD25-a case report of rare entity.
Zaremba-Pataj E; Patkowska E; Krzywdzińska A; Szumera-Ciećkiewicz A; Chlebowska-Tuz J
J Hematop; 2023 Mar; 16(1):39-47. PubMed ID: 38175371
[TBL] [Abstract] [Full Text] [Related]
6. Phase 2 study of ibrutinib plus venetoclax in Japanese patients with relapsed/refractory mantle cell lymphoma.
Goto H; Ito S; Kizaki M; Yamaguchi M; Fukuhara N; Kato K; Saito T; Terui Y; Okubo S; Soshin T; Zeng J; Honda H; Badawi M; Ross JA; Izutsu K
Int J Clin Oncol; 2024 Feb; 29(2):232-240. PubMed ID: 38157190
[TBL] [Abstract] [Full Text] [Related]
7. First-in-Human Study with Preclinical Data of BCL-2/BCL-xL Inhibitor Pelcitoclax in Locally Advanced or Metastatic Solid Tumors.
Lakhani NJ; Rasco D; Wang H; Men L; Liang E; Fu T; Collins MC; Min P; Yin Y; Davids MS; Yang D; Zhai Y
Clin Cancer Res; 2024 Feb; 30(3):506-521. PubMed ID: 37971712
[TBL] [Abstract] [Full Text] [Related]
8. Discovery of Selective and Potent Macrocyclic CDK9 Inhibitors for the treatment of Osimertinib-Resistant Non-Small-Cell lung cancer.
Wu T; Yu B; Xu Y; Du Z; Zhang Z; Wang Y; Chen H; Zhang LA; Chen R; Ma F; Gong W; Yu S; Qiu Z; Wu H; Xu X; Wang J; Li Z; Bian J
J Med Chem; 2023 Nov; 66(22):15340-15361. PubMed ID: 37870244
[TBL] [Abstract] [Full Text] [Related]
9. The novel small molecule BH3 mimetic nobiletin synergizes with vorinostat to induce apoptosis and autophagy in small cell lung cancer.
Li YQ; Fan F; Wang YR; Li LY; Cao YJ; Gu SM; Liu SS; Zhang Y; Wang J; Tie L; Pan Y; Li HF; Li XJ
Biochem Pharmacol; 2023 Oct; 216():115807. PubMed ID: 37716621
[TBL] [Abstract] [Full Text] [Related]
10. Bcl-2 family inhibitors sensitize human cancer models to therapy.
Valentini E; Di Martile M; Brignone M; Di Caprio M; Manni I; Chiappa M; Sergio I; Chiacchiarini M; Bazzichetto C; Conciatori F; D'Aguanno S; D'Angelo C; Ragno R; Russillo M; Colotti G; Marchesi F; Bellone ML; Dal Piaz F; Felli MP; Damia G; Del Bufalo D
Cell Death Dis; 2023 Jul; 14(7):441. PubMed ID: 37460459
[TBL] [Abstract] [Full Text] [Related]
11. Scoparone induces both apoptosis and ferroptosis via multiple mechanisms in non-small-cell lung cancer cells.
Shen H; Wei Y; Yang Q; Cai Y; Zhu K; Chen X
Toxicol In Vitro; 2023 Sep; 91():105627. PubMed ID: 37315743
[TBL] [Abstract] [Full Text] [Related]
12. Dynamic BH3 profiling identifies pro-apoptotic drug combinations for the treatment of malignant pleural mesothelioma.
Potter DS; Du R; Bohl SR; Chow KH; Ligon KL; Bueno R; Letai A
Nat Commun; 2023 May; 14(1):2897. PubMed ID: 37210412
[TBL] [Abstract] [Full Text] [Related]
13. Chimeric TIM-4 receptor-modified T cells targeting phosphatidylserine mediates both cytotoxic anti-tumor responses and phagocytic uptake of tumor-associated antigen for T cell cross-presentation.
Cieniewicz B; Bhatta A; Torabi D; Baichoo P; Saxton M; Arballo A; Nguyen L; Thomas S; Kethar H; Kukutla P; Shoaga O; Yu B; Yang Z; Fate M; Oliveira E; Ning H; Corey L; Corey D
Mol Ther; 2023 Jul; 31(7):2132-2153. PubMed ID: 37194236
[TBL] [Abstract] [Full Text] [Related]
14. Polypeptide antibiotic actinomycin D induces mcl-1 uncanonical downregulation in lung cancer cell apoptosis.
Chen CL; Tseng PC; Chao YP; Shen TJ; Jhan MK; Wang YT; Nguyen TT; Lin CF
Life Sci; 2023 May; 321():121615. PubMed ID: 37001403
[TBL] [Abstract] [Full Text] [Related]
15. Expression of plant-produced anti-PD-L1 antibody with anoikis sensitizing activity in human lung cancer cells via., suppression on epithelial-mesenchymal transition.
Phetphoung T; Malla A; Rattanapisit K; Pisuttinusart N; Damrongyot N; Joyjamras K; Chanvorachote P; Phakham T; Wongtangprasert T; Strasser R; Chaotham C; Phoolcharoen W
PLoS One; 2022; 17(11):e0274737. PubMed ID: 36367857
[TBL] [Abstract] [Full Text] [Related]
16. GANT61/BI-847325 combination: a new hope in lung cancer treatment.
El-Kishky AHM; Moussa N; Helmy MW; Haroun M
Med Oncol; 2022 Jul; 39(10):144. PubMed ID: 35834029
[TBL] [Abstract] [Full Text] [Related]
17. 5-
Suksamai D; Racha S; Sriratanasak N; Chaotham C; Aphicho K; Lin ACK; Chansriniyom C; Suwanborirux K; Chamni S; Chanvorachote P
Mar Drugs; 2022 Mar; 20(4):. PubMed ID: 35447911
[TBL] [Abstract] [Full Text] [Related]
18. Circulating tumor DNA predicts therapeutic outcome in mantle cell lymphoma.
Lakhotia R; Melani C; Dunleavy K; Pittaluga S; Saba N; Lindenberg L; Mena E; Bergvall E; Lucas AN; Jacob A; Yusko E; Steinberg SM; Jaffe ES; Wiestner A; Wilson WH; Roschewski M
Blood Adv; 2022 Apr; 6(8):2667-2680. PubMed ID: 35143622
[TBL] [Abstract] [Full Text] [Related]
19. Overcoming acquired resistance to third-generation EGFR inhibitors by targeting activation of intrinsic apoptotic pathway through mcl-1 inhibition, Bax activation, or both.
Ma G; Deng Y; Qian L; Vallega KA; Zhang G; Deng X; Owonikoko TK; Ramalingam SS; Fang DD; Zhai Y; Sun SY
Oncogene; 2022 Mar; 41(12):1691-1700. PubMed ID: 35102249
[TBL] [Abstract] [Full Text] [Related]
20. Lucanthone, Autophagy Inhibitor, Enhances the Apoptotic Effects of TRAIL through miR-216a-5p-Mediated DR5 Upregulation and DUB3-Mediated mcl-1 Downregulation.
Yoon JY; Woo SM; Seo SU; Song SR; Lee SG; Kwon TK
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008442
[TBL] [Abstract] [Full Text] [Related]
[Next]
